Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy.
about
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's DiseaseSumoylation in Synaptic Function and DysfunctionThe Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and TherapyPreventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau.Promoting autophagic clearance: viable therapeutic targets in Alzheimer's disease.Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models.Protein phosphorylation in neurodegeneration: friend or foe?Latest treatment options for Alzheimer's disease, Parkinson's disease dementia and dementia with Lewy bodies.The ongoing pursuit of neuroprotective therapies in Parkinson disease.Tau-directed approaches for the treatment of Alzheimer's disease: focus on leuco-methylthioninium.Methylene Blue Inhibits Caspases by Oxidation of the Catalytic Cysteine.Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer's Disease Mouse Model.Alzheimer disease: modeling an Aβ-centered biological network.Tau aggregation inhibitors: the future of Alzheimer's pharmacotherapy?[Mechanisms of Alzheimer's disease : Neuronal hyperactivity and hypoactivity as new therapeutic targets].
P2860
Q26739412-E8DF6B2A-ACD8-4113-8A6D-FE64E1F0D1DBQ26747536-9305EB31-C744-4F07-8E9A-3352C4762907Q28119005-7D760371-7416-4C2F-97A4-12A07000C956Q30649677-A6AA6EF8-B5E3-4806-81C7-625196FE2D5DQ35064974-75FC3AEA-4851-472F-8F84-C033BB99EB64Q35558517-EC3FBBE0-84AC-4D7A-8FD1-EE587203E562Q38214594-93CB3C1A-DCED-4E13-A4DE-FE33B22795A7Q38225930-A55354A0-441A-452F-B8BE-63618FF324D9Q38275171-F545BC79-63F0-4C79-9775-9DC5A6C54033Q38715233-E9E0937C-2A77-46DA-A3FA-B6083AB9D1A8Q38833034-FF6DE890-F2CC-47F0-907E-1848B19EE3F6Q46784990-30CFD354-9792-4E7E-9816-944D81AA126CQ47878052-53B33415-0E39-4494-81B1-D6944BDABA54Q48239696-F5AF1906-A9D4-4922-87E8-DC095040CB94Q53372356-2915DA1B-61EF-4934-8E28-7866CE964C1B
P2860
Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Methylene blue does not revers ...... 4510 mouse model of tauopathy.
@en
Methylene blue does not revers ...... 4510 mouse model of tauopathy.
@nl
type
label
Methylene blue does not revers ...... 4510 mouse model of tauopathy.
@en
Methylene blue does not revers ...... 4510 mouse model of tauopathy.
@nl
prefLabel
Methylene blue does not revers ...... 4510 mouse model of tauopathy.
@en
Methylene blue does not revers ...... 4510 mouse model of tauopathy.
@nl
P2093
P2860
P1433
P1476
Methylene blue does not revers ...... 4510 mouse model of tauopathy.
@en
P2093
Allyson Roe
George A Carlson
Manuela Polydoro
Rose Pitstick
Taylor Friedman
P2860
P356
10.1016/J.NEULET.2014.01.013
P407
P577
2014-01-21T00:00:00Z